Croatia vs Northern Africa and Western Asia: Percentage of bloodstream infection due to methicillin-resistant
Croatia
53.8%
in 2022
Northern Africa and Western Asia
42.1%
in 2022
Croatia rank
9th
Northern Africa and Western Asia rank
8th
Percentage of bloodstream infection due to methicillin-resistant over time
- Croatia
- Northern Africa and Western Asia
How they compare
Croatia currently reports 53.8% against 42.1% in Northern Africa and Western Asia, a difference of 11.7%.
That makes Croatia's figure about 1.3 times Northern Africa and Western Asia's.
The two have swapped places 2 times across 6 shared years of data; in 2017 it was Croatia ahead.
Croatia ranks 9th and Northern Africa and Western Asia ranks 8th of 50 countries.
Across the 2 decades both report, Croatia averaged higher in 1 and Northern Africa and Western Asia in 1.
Head to head by decade
| Decade | Croatia | Northern Africa and Western Asia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 26.6% | 33.9% | 7.3% | Northern Africa and Western Asia |
| 2020s | 56.8% | 44.4% | 12.4% | Croatia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher percentage of bloodstream infection due to methicillin-resistant, Croatia or Northern Africa and Western Asia?
- Croatia, at 53.8% against 42.1% in Northern Africa and Western Asia as of 2022.
- What is the difference in percentage of bloodstream infection due to methicillin-resistant between Croatia and Northern Africa and Western Asia?
- 11.7%, with Croatia ahead.
- How many years of comparable data are there for Croatia and Northern Africa and Western Asia?
- 6 years are reported by both, from 2017 to 2022.
- How do Croatia and Northern Africa and Western Asia rank globally for percentage of bloodstream infection due to methicillin-resistant?
- Croatia ranks 9th and Northern Africa and Western Asia ranks 8th of 50 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.